GLP-3RT 12MG
$300.00
GLP-3RT 12MG is a GGG tri-agonist research peptide that activates GLP-1, GIP, and glucagon receptors, enhancing basal metabolism while supporting appetite control and delayed gastric emptying. This multi-receptor activity provides a broader approach to obesity research compared to traditional GLP-1 agonists.
GLP-3RT is a synthetic GLP-based peptide analogue of approximately 30–35 amino acids with a molecular weight of ~3,500–4,200 Da and ≥99% research-grade purity. It is supplied as a white to off-white lyophilized powder in 12 mg vials for in vitro and laboratory research use only.
GLP-3RT 12MG is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, thereby increasing basal metabolism. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.
Chemical Information
- Chemical Name: GLP-3RT (Glucagon-Like Peptide–based Research Tri-Modified / RT variant)
- Molecular Formula: — (peptide; exact formula varies based on proprietary modifications and salt form)
- Molecular Weight: ~3,500–4,200 Da (approximate; manufacturer dependent)
- Peptide Length: ~30–35 amino acids (GLP-based analogue)
- Classification: Synthetic peptide hormone analogue (GLP receptor–related research peptide)
- Purity: ≥99% (HPLC, research grade)
- Appearance: White to off-white lyophilized powder
- Net Content: 12 mg
Additional Information
- Sequence Description: Modified GLP-based peptide incorporating stabilization and resistance-enhancing structural changes
- CAS Number: Not assigned / not universally registered
- Salt Form: Typically acetate or TFA (manufacturer dependent)
Storage Conditions
- Store lyophilized powder at –20 °C or below
- Protect from light, heat, and moisture
- Avoid repeated freeze–thaw cycles after reconstitution
Intended Use
- For research use only (RUO)
- Intended for in vitro and laboratory research applications
- Not for human or veterinary use
Clinical Data:
- GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
- GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
- GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
| Size |
1MG (1000MCG) ,2MG (2000MCG) |
|---|

Reviews
There are no reviews yet.